FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1257-1262 October 25, 2001 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

A 26-year-old graduate student with an eight-year history of asthma has shortness of breath and cough an average of three times a week and nighttime wheezing about twice a month. He is an avid runner and wheezes routinely after exercise. Office spirometry shows that the forced expiratory volume in one second (FEV₁) is 85 percent of the predicted value. What treatment . . . [Full Text of this Article]

The Clinical Problem

Definition of Mild Asthma

Strategies and Evidence

Treatment of Mild Intermittent Asthma

            Patient Education and Monitoring

            ₂-Agonists

Treatment of Mild Persistent Asthma

            Inhaled Corticosteroids

            Nedocromil and Cromolyn Sodium

            Agents That Modify the Leukotriene Pathway

Treatment of Asthma Induced by Cold Air and Exercise

Areas of Uncertainty

Guidelines

Conclusions and Recommendations

Source Information

From the Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, Chicago.

Address reprint requests to Dr. Naureckas at the University of Chicago, Section of Pulmonary and Critical Care Medicine, 5841 S. Maryland MC 6076, Chicago, IL 60637, or at tnaureka@medicine.bsd.uchicago.edu.

References

This article has been cited by other articles:

• Falliers, C. J. (2005). Emergent Asthma: Endogenous, Exogenous, or Iatrogenous. Chest 127: 427-429 [Full Text]  
• Murai, A., Abe, M., Hayashi, Y., Sakata, N., Katsuragi, T., Tanaka, K. (2005). Comparison Study between the Mechanisms of Allergic Asthma Amelioration by a Cysteinyl-Leukotriene Type 1 Receptor Antagonist Montelukast and Methylprednisolone. J. Pharmacol. Exp. Ther. 312: 432-440 [Abstract] [Full Text]  
• Bonnin, A. J., Marinkovich, V. A., Romagnoli, M., Fabbri, L. M., Naureckas, E. T., Solway, J. (2002). Mild Asthma. NEJM 346: 1335-1336 [Full Text]